Step 5: Effective Drug Treatment of HIV
See also Antiretroviral Therapy, Adherence, and Initiating Treatment
Active Resources: 19
-
The NHC offers free online continuing education for novice-to-expert health professionals, students, and faculty.
Type: Online TrainingPublication Date: 9/14/2020 -
Slides from a 1-day course for primary care physicians and mid-level clinicians, which combines the latest research with current treatment guidelines for managing patients with HIV.
Type: Slide SetsPublication Date: 7/31/2020 -
Training slides covering U.S. HHS treatment recommendations related to starting antiretroviral therapy (ART) in people with HIV infection.
Type: Slide SetsPublication Date: 3/1/2020 -
Training slides cover HHS recommendations for treatment of transgender people with HIV.
Type: Slide SetsPublication Date: 1/31/2020 -
This training slide set covers aging-related concerns for people with HIV, including management of ART.
Type: Slide SetsPublication Date: 1/31/2020 -
Excerpt from Introduction: The Department of Health and Human Services Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, a working group of the Of
Type: Antiretroviral GuidelinesPublication Date: 12/24/2019 -
Excerpt from the Guidelines Introduction: "The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of
Type: Antiretroviral GuidelinesPublication Date: 12/18/2019 -
Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment.
Type: Online TrainingPublication Date: 12/4/2019 -
In response to newly identified, community-based HIV epidemics, the AETC NCRC has pulled together the following AETC Program and U.S.
Type: ToolkitsPublication Date: 6/10/2019 -
Guidelines for treating HIV-infected infants, children, and adolescents, including clinical monitoring, initiation of treatment, pediatric-specific drug information, and managing complications.
Type: Antiretroviral GuidelinesPublication Date: 4/16/2019Review Date: 4/14/2020 -
This glossary of HIV/AIDS-related terms includes brief lay-oriented descriptions and illustrations. Materials are in the public domain and may be used freely.
Type: Image LibraryPublication Date: 2/20/2019Review Date: 2/20/2019 -
Northeast/Caribbean (NECA) AETC offers online continuing education accredited videos and monographs.
Type: Online and Self-Paced LearningPublication Date: 2/5/2019Review Date: 9/19/2020 -
Webinar slides, recording, and resources. From Pacific AETC's HIV Learning Network session on linkage and retention in care for people with HIV.
Type: Self-Study MaterialsPublication Date: 2/28/2018 -
Presented by:Nimish Patel, PharmD, PhD, AAHIVPAssistant ProfessorPharmacy PracticeType: Webinar RecordingsPublication Date: 1/12/2017
-
Archived webinars on clinical topics from the MidAtlantic AETC.
Type: Webinar RecordingsPublication Date: 6/8/2016 -
To help HIV care providers engage patients in care and transmission prevention, the Centers for Disease Control and Prevention (CDC) developed a new and comprehensive Prevention IS Care re
Type: ToolkitsPublication Date: 5/17/2016Review Date: 2/20/2019 -
This toolkit provides different assessment tools and guides to assist in addressing common health literacy issues in clinical care systems. The following are included in this CDC toolkit:
Type: ToolkitsPublication Date: 2/2/2016 -
36 evidence-based recommendations are provided for interventions to optimize the HIV care environment; increase HIV testing and linkage to care, treatment coverage, retention in care, and viral sup
Type: Primary Care GuidelinesPublication Date: 11/9/2015 -
Revised Recommendations for the Use of Hormonal Contraception among Women at High Risk for HIV Infection or Infected with HIV
MMWR Weekly. June 22, 2012 / 61(24);449-452Type: Primary Care GuidelinesPublication Date: 6/22/2012
Archive Resources: 14
Charts, Tables & Posters
-
9/4/2015
-
7/1/2015
-
8/22/2014
-
6/1/2013 (reviewed: 1/11/2017)
Toolkits
-
4/29/2015
-
7/31/2014 (reviewed: 2/12/2018)
Webinar Recordings
-
2/19/2015 (reviewed: 1/3/2020)
Videos
-
7/17/2014
-
9/2/2013
Patient Information
-
7/7/2014 (reviewed: 5/8/2019)
Pocket Guides
-
2/1/2014
Slide Sets
-
1/15/2014
Primary Care Guidelines
-
11/13/2013 (reviewed: 5/17/2019)
Manuals
-
11/1/2013
Articles: 8
-
Immediate ART Initiation: Guide for Clinicians
Immediate antiretroviral therapy (ART) refers to starting HIV treatment as soon as possible after the diagnosis of HIV infection, preferably on the first clinic visit (and even on the same day the HIV diagnosis is made). This strategy also is known as "rapid ART," "same-day ART," and "treatment...
-
AETCs at the 2018 Ryan White Conference
The AETC Program was well represented at the 2018 National Ryan White Conference on HIV Care & Treatment. The AETC National Coordinating Resource Center exhibited an array of AETC Program developed resources and promotional items.
TitleSession IDTypePresenters/ PanelistsDate/time... -
Ibalizumab Approved for Persons with Multidrug Resistant HIV
Ibalizumab (TNX-355), an entry inhibitor, has been approved by the FDA for use in persons with an extensive ARV treatment history and multidrug resistant HIV who are on a failing ARV regimen. Ibalizumab (trade name: Trogarzo) is a monoclonal antibody that binds the CD4 receptor and blocks HIV...
-
Rifampin Drug-Drug Interactions with Newer Antiretrovirals (TAF, Bictegravir, Dolutegravir)
Treatment of tuberculosis (TB) in HIV-infected persons remains challenging, in part because of drug interactions between rifampin and some ARVs that may compromise antiretroviral therapy (ART). Three studies presented at CROI provide clinicians with additional guidance on how to manage certain...
-
Recap: 17th Ryan White HIV/AIDS Program Clinical Care Conference
Highlights from Laura W. Cheever, MD, ScM, HRSA HIV/AIDS Bureau Associate Administrator and Conference Co-Chair
The field of HIV/AIDS care and treatment continues to evolve rapidly. Groundbreaking developments in HIV research are regularly presented at international meetings and...
-
CROI 2017: Failure of Dolutegravir Monotherapy
Leading up to this year, some researchers and clinicians had optimistically viewed dolutegravir an invincible ARV, a drug so mighty that it was unlikely to fail, and even more unlikely to be victim to emergent resistance mutations. Two presentations at CROI demonstrated the...
-
Efavirenz, Dolutegravir, and Darunavir: Pharmacokinetics during Pregnancy
Three studies presented at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) explored the pharmacokinetics of antiretrovirals administered during pregnancy. These studies support the use of standard-dose efavirenz, once-daily dolutegravir, and BID ritonavir-boosted...
-
Switching from TDF/FTC to TAF/FTC
Researchers at the 2016 Conference on Retroviruses and Opportunistic Infections presented results from a randomized double-blind, double-dummy switch study of TAF/FTC. Over 660 patients with virologic suppression on TDF/FTC-containing 3-drug regimens were either switched to TAF/FTC (200/10 mg...